home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410m.zip
/
M94A2263.TXT
< prev
next >
Wrap
Text File
|
1994-10-25
|
3KB
|
51 lines
Document 2263
DOCN M94A2263
TI Evaluation of a prevention indicator in prenatal clinics in Brazil.
DT 9412
AU Perini N; Pinheiro M; Bernardo E; Oliveira D; Paranhos N; Loures L;
Lauria L; Health Department of Federal District, Brasilia, DF, Brazil.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):344 (abstract no. PC0312). Unique
Identifier : AIDSLINE ICA10/94370312
AB OBJECTIVES: Indicators (Priority Prevention Indicators, PPIs) for
monitoring National AIDS Programs (NAP) were developed by GPA/WHO. PPI-5
(HIV seroprevalence in pregnant women, 15-24 years, attending prenatal
clinics, non-linked) was field tested by the Brasilia Public Health
System (BPHS), in collaboration with the National STD/AIDS Control
Programme, Brazil. METHODS: After identifying all BPHS prenatal clinics
(49), the participating Centers were selected by systematic sampling,
based on the number of pregnant women seen at each Center. From each
enrolled Clinic, 75 samples were to be collected (a total of 1500). All
pregnant women in their first clinic visit had their age and parity
recorded. A blood sample was collected in two types of filter paper
(Whatman 4 and Mellita coffee filter); a serum sample was also obtained
to be used as a gold-standard. RESULTS: The main problems identified in
implementing PPI-5 within the routine of the BPHS prenatal program were:
(1) the need to prepare a document to all participant Centers,
describing, in general terms, the PPI objectives and specifying the
tasks and responsibilities of each Center within the evaluation; (2) the
need of involving the Directors of the participating Centers since the
planning stage. Although they did not interfere with the data
collection, they did not considered themselves as part of the PPI; (3)
the need to establish a formal training period for those involved with
data collection, including the eventual replacements (vacations, leave
of absence, etc.); (4) the need to develop forms to be used by all
participating Centers; the participation of the Center personnel in this
stage is mandatory and (5) the need to involve the PPI supervision with
the Centers routine problems; in one participating Clinic, the data
collection was suspended because pregnancy tests were not available.
CONCLUSIONS: The inclusion of PPI-5 in the routine of prenatal clinics
in the BPHS have shown the feasibility of carrying out these indicators
to monitor NAPs. The problems identified are easily solved by an
adequate planning phase and a closer contact between the PPI supervision
and the participating Centers leadership.
DE Adolescence Adult Brazil/EPIDEMIOLOGY *Developing Countries
Feasibility Studies Female *Health Education Health Priorities Human
HIV Infections/EPIDEMIOLOGY/*PREVENTION & CONTROL/TRANSMISSION HIV
Seroprevalence/*TRENDS Infant, Newborn Pregnancy Pregnancy
Complications, Infectious/EPIDEMIOLOGY/ETIOLOGY/ *PREVENTION & CONTROL
*Prenatal Care Program Evaluation MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).